Schedule 13D ownership disclosure

ZETA ACQUISITION CORP II

Security class unavailable

Event date: 2018-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000540
Form type
SC 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Jul 02, 2018
Reporting period
Jun 28, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub